FDA Orange Book · active-ingredient family
Ibuprofen; oxycodone hydrochloride
Ibuprofen; oxycodone hydrochloride is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:COMBUNOX · NDA 021378
1
Brand (NDA)
3
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| COMBUNOXRLD | FOREST LABS | NDA 021378 | — | Nov 26, 2004 |
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| OXYCODONE HYDROCHLORIDE AND IBUPROFEN | ACTAVIS ELIZABETH | ANDA 078769 | — | Jan 04, 2008 | |
| OXYCODONE HYDROCHLORIDE AND IBUPROFEN | BARR LABS INC | ANDA 078316 | — | Nov 29, 2007 | |
| OXYCODONE HYDROCHLORIDE AND IBUPROFEN | WATSON LABS | ANDA 078394 | — | Nov 26, 2007 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Ibuprofen; oxycodone hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

